Integra LifeSciences Holdings Corp. (IART)
13.33
-0.12
(-0.89%)
USD |
NASDAQ |
Oct 20, 16:00
12.25
-1.08
(-8.10%)
After-Hours: 07:25
Integra LifeSciences Holdings Research and Development Expense (TTM) : 68.59M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.59M |
| March 31, 2026 | 68.30M |
| December 31, 2025 | 70.83M |
| September 30, 2025 | 76.44M |
| June 30, 2025 | 82.32M |
| March 31, 2025 | 85.91M |
| December 31, 2024 | 85.89M |
| September 30, 2024 | 91.34M |
| June 30, 2024 | 87.28M |
| March 31, 2024 | 84.84M |
| December 31, 2023 | 82.84M |
| September 30, 2023 | 74.13M |
| June 30, 2023 | 71.45M |
| March 31, 2023 | 72.11M |
| December 31, 2022 | 71.65M |
| September 30, 2022 | 81.46M |
| June 30, 2022 | 82.05M |
| March 31, 2022 | 76.68M |
| December 31, 2021 | 74.50M |
| September 30, 2021 | 73.06M |
| June 30, 2021 | 71.51M |
| March 31, 2021 | 67.93M |
| December 31, 2020 | 73.22M |
| September 30, 2020 | 67.15M |
| June 30, 2020 | 67.55M |
| Date | Value |
|---|---|
| March 31, 2020 | 70.88M |
| December 31, 2019 | 65.66M |
| September 30, 2019 | 73.58M |
| June 30, 2019 | 74.88M |
| March 31, 2019 | 76.36M |
| December 31, 2018 | 78.04M |
| September 30, 2018 | 74.92M |
| June 30, 2018 | 69.65M |
| March 31, 2018 | 66.29M |
| December 31, 2017 | 63.46M |
| September 30, 2017 | 60.18M |
| June 30, 2017 | 60.07M |
| March 31, 2017 | 59.00M |
| December 31, 2016 | 57.96M |
| September 30, 2016 | 57.34M |
| June 30, 2016 | 56.35M |
| March 31, 2016 | 55.57M |
| December 31, 2015 | 53.67M |
| September 30, 2015 | 52.54M |
| June 30, 2015 | 51.73M |
| March 31, 2015 | 51.08M |
| December 31, 2014 | 51.10M |
| September 30, 2014 | 53.45M |
| June 30, 2014 | 53.38M |
| March 31, 2014 | 51.94M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Penumbra, Inc. | 75.84M |
| Boston Scientific Corp. | 2.153B |
| Globus Medical, Inc. | 147.06M |
| Sight Sciences, Inc. | 10.85M |
| Abbott Laboratories | 3.128B |